Venous Thromboembolism: Gender Effects and Gender-Specific Risk Factors for Women

Susan Murin, Lisa Moores, Kathryn L. Bilello, Richard A. Matthay

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter discusses the symptoms, epidemiology, and risk factors of venous thromboembolism (VTE). It focuses on gender-specific risk factors for VTE among women, as well as on special considerations in the diagnostic and therapeutic approaches to VTE in the pregnant patients. The incidence of VTE increases markedly with increasing age. The incidence of VTE does not appear to vary significantly by gender, as evidenced by a lack of consistency in the magnitude and even direction of effect of gender in a variety of epidemiologic studies of varying designs. The main influence of gender upon VTE is the relationship between female gender and several well-recognized clinical risk factors for VTE-Oral contraceptives (OCs) use, hormone replacement therapy (HRT), estrogen receptor modulator therapy, and pregnancy. The fact that women of childbearing age do not appear to have a substantially greater incidence of VTE compared with age-matched men may reflect an offsetting of these female-specific risk factors by other risk factors that are more common in men, such as trauma. Hormonal therapies are associated with a 2- to 3-fold increase in VTE incidence. The pregnancy state is associated with a 3- to 5-fold increase in VTE risk, and thromboembolism is a major cause of peripartum death.

Original languageEnglish (US)
Title of host publicationPrinciples of Gender-Specific Medicine
PublisherElsevier Inc.
Pages332-346
Number of pages15
Volume1
ISBN (Print)9780124409057
DOIs
StatePublished - 2004

Fingerprint

Venous Thromboembolism
Incidence
Epidemiology
Estrogen Receptor Modulators
Oral Contraceptives
Peripartum Period
Pregnancy
Hormones
Thromboembolism
Hormone Replacement Therapy
Epidemiologic Studies
Cause of Death
Therapeutics

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Murin, S., Moores, L., Bilello, K. L., & Matthay, R. A. (2004). Venous Thromboembolism: Gender Effects and Gender-Specific Risk Factors for Women. In Principles of Gender-Specific Medicine (Vol. 1, pp. 332-346). Elsevier Inc.. https://doi.org/10.1016/B978-012440905-7/50299-1

Venous Thromboembolism : Gender Effects and Gender-Specific Risk Factors for Women. / Murin, Susan; Moores, Lisa; Bilello, Kathryn L.; Matthay, Richard A.

Principles of Gender-Specific Medicine. Vol. 1 Elsevier Inc., 2004. p. 332-346.

Research output: Chapter in Book/Report/Conference proceedingChapter

Murin, S, Moores, L, Bilello, KL & Matthay, RA 2004, Venous Thromboembolism: Gender Effects and Gender-Specific Risk Factors for Women. in Principles of Gender-Specific Medicine. vol. 1, Elsevier Inc., pp. 332-346. https://doi.org/10.1016/B978-012440905-7/50299-1
Murin S, Moores L, Bilello KL, Matthay RA. Venous Thromboembolism: Gender Effects and Gender-Specific Risk Factors for Women. In Principles of Gender-Specific Medicine. Vol. 1. Elsevier Inc. 2004. p. 332-346 https://doi.org/10.1016/B978-012440905-7/50299-1
Murin, Susan ; Moores, Lisa ; Bilello, Kathryn L. ; Matthay, Richard A. / Venous Thromboembolism : Gender Effects and Gender-Specific Risk Factors for Women. Principles of Gender-Specific Medicine. Vol. 1 Elsevier Inc., 2004. pp. 332-346
@inbook{8ff8de66fd964c349daa944beec4b079,
title = "Venous Thromboembolism: Gender Effects and Gender-Specific Risk Factors for Women",
abstract = "This chapter discusses the symptoms, epidemiology, and risk factors of venous thromboembolism (VTE). It focuses on gender-specific risk factors for VTE among women, as well as on special considerations in the diagnostic and therapeutic approaches to VTE in the pregnant patients. The incidence of VTE increases markedly with increasing age. The incidence of VTE does not appear to vary significantly by gender, as evidenced by a lack of consistency in the magnitude and even direction of effect of gender in a variety of epidemiologic studies of varying designs. The main influence of gender upon VTE is the relationship between female gender and several well-recognized clinical risk factors for VTE-Oral contraceptives (OCs) use, hormone replacement therapy (HRT), estrogen receptor modulator therapy, and pregnancy. The fact that women of childbearing age do not appear to have a substantially greater incidence of VTE compared with age-matched men may reflect an offsetting of these female-specific risk factors by other risk factors that are more common in men, such as trauma. Hormonal therapies are associated with a 2- to 3-fold increase in VTE incidence. The pregnancy state is associated with a 3- to 5-fold increase in VTE risk, and thromboembolism is a major cause of peripartum death.",
author = "Susan Murin and Lisa Moores and Bilello, {Kathryn L.} and Matthay, {Richard A.}",
year = "2004",
doi = "10.1016/B978-012440905-7/50299-1",
language = "English (US)",
isbn = "9780124409057",
volume = "1",
pages = "332--346",
booktitle = "Principles of Gender-Specific Medicine",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Venous Thromboembolism

T2 - Gender Effects and Gender-Specific Risk Factors for Women

AU - Murin, Susan

AU - Moores, Lisa

AU - Bilello, Kathryn L.

AU - Matthay, Richard A.

PY - 2004

Y1 - 2004

N2 - This chapter discusses the symptoms, epidemiology, and risk factors of venous thromboembolism (VTE). It focuses on gender-specific risk factors for VTE among women, as well as on special considerations in the diagnostic and therapeutic approaches to VTE in the pregnant patients. The incidence of VTE increases markedly with increasing age. The incidence of VTE does not appear to vary significantly by gender, as evidenced by a lack of consistency in the magnitude and even direction of effect of gender in a variety of epidemiologic studies of varying designs. The main influence of gender upon VTE is the relationship between female gender and several well-recognized clinical risk factors for VTE-Oral contraceptives (OCs) use, hormone replacement therapy (HRT), estrogen receptor modulator therapy, and pregnancy. The fact that women of childbearing age do not appear to have a substantially greater incidence of VTE compared with age-matched men may reflect an offsetting of these female-specific risk factors by other risk factors that are more common in men, such as trauma. Hormonal therapies are associated with a 2- to 3-fold increase in VTE incidence. The pregnancy state is associated with a 3- to 5-fold increase in VTE risk, and thromboembolism is a major cause of peripartum death.

AB - This chapter discusses the symptoms, epidemiology, and risk factors of venous thromboembolism (VTE). It focuses on gender-specific risk factors for VTE among women, as well as on special considerations in the diagnostic and therapeutic approaches to VTE in the pregnant patients. The incidence of VTE increases markedly with increasing age. The incidence of VTE does not appear to vary significantly by gender, as evidenced by a lack of consistency in the magnitude and even direction of effect of gender in a variety of epidemiologic studies of varying designs. The main influence of gender upon VTE is the relationship between female gender and several well-recognized clinical risk factors for VTE-Oral contraceptives (OCs) use, hormone replacement therapy (HRT), estrogen receptor modulator therapy, and pregnancy. The fact that women of childbearing age do not appear to have a substantially greater incidence of VTE compared with age-matched men may reflect an offsetting of these female-specific risk factors by other risk factors that are more common in men, such as trauma. Hormonal therapies are associated with a 2- to 3-fold increase in VTE incidence. The pregnancy state is associated with a 3- to 5-fold increase in VTE risk, and thromboembolism is a major cause of peripartum death.

UR - http://www.scopus.com/inward/record.url?scp=84902060772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902060772&partnerID=8YFLogxK

U2 - 10.1016/B978-012440905-7/50299-1

DO - 10.1016/B978-012440905-7/50299-1

M3 - Chapter

AN - SCOPUS:84902060772

SN - 9780124409057

VL - 1

SP - 332

EP - 346

BT - Principles of Gender-Specific Medicine

PB - Elsevier Inc.

ER -